Trials / Withdrawn
WithdrawnNCT05302713
Antiorbital Calcium in Chronic Conditions
Evaluating Changes in Quality of Life and Epigenetic Methylation From Antiorbital Ionic Calcium in Older Adults With Chronic Conditions
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- National University of Natural Medicine · Academic / Other
- Sex
- All
- Age
- 55 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the mechanistic effects of an ionic calcium supplement in adults with atrial fibrillation, osteoarthritis, and hypertension. The study aims to determine if ionic calcium supplementation affects quality of life, rate of biological aging, bone densitometry, and blood biomarkers of bone metabolism over a six month period compared to non-ionic calcium comparator supplement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ionic Calcium | Ionic calcium (IC), a calcium in a free ionic state (i.e., non-protein bound), is purported to improve calcium uptake and homeostasis leading to improved cellular signaling that may have been disrupted through environmental and lifestyle stressors. |
| DIETARY_SUPPLEMENT | Calcium Carbonate | Calcium carbonate supplementation in a solution identical in appearance, consistency, and taste to the intervention supplement. |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2024-12-01
- Completion
- 2025-12-01
- First posted
- 2022-03-31
- Last updated
- 2024-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05302713. Inclusion in this directory is not an endorsement.